Europe Single-Use Bioreactors Market (2026-2031)
The Europe Single-Use Bioreactors Market was valued at $1605.4 Million in 2026 and projected to reach to $2686.5 Million by 2031, representing a compound annual growth rate of 10.8%. Europe's single-use bioreactors market is poised for sustained expansion through 2031, driven by increasing biopharmaceutical production demands, stringent regulatory compliance requirements, and technological advancements in manufacturing efficiency.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Europe Single-Use Bioreactors Market Trends and Insights
- This 10.8% compound annual growth rate reflects Europe's strong commitment to biopharmaceutical manufacturing innovation and regulatory compliance.
- Europe leads in adopting single-use technologies due to stringent quality standards, advanced healthcare infrastructure, and significant investment in cell and gene therapy development across the region. The European market benefits from a mature pharmaceutical ecosystem and increasing demand for flexible, cost-effective manufacturing solutions.
- Europe's bioreactor adoption is driven by the region's concentration of contract manufacturing organizations (CMOs) and biopharmaceutical companies seeking to reduce capital expenditure and production timelines.
- Between 2026 and 2031, Europe is expected to maintain its position as a key growth hub, supported by favorable regulatory frameworks and accelerating clinical pipeline activities throughout the continent..
Key Market Statistics
- CAGR (2026-2031) 10.8% CAGR
- Market Size, 2026 ~USD 1605.4 Million
- Forecast, 2031 ~USD 2686.5 Million
- Geography Europe
Europe Single-Use Bioreactors Market Overview
Market Valuation & Growth :
Europe's single-use bioreactors market is valued at $1,605.4 million in 2026 and is projected to reach $2,686.5 million by 2031, representing a robust 10.8% CAGR, demonstrating strong regional demand for advanced biopharmaceutical manufacturing solutions.
Regulatory Leadership :
Europe's stringent quality standards and regulatory frameworks drive accelerated adoption of single-use bioreactor technologies, positioning the region as a global leader in compliance-driven biopharmaceutical manufacturing innovation.
Germany's Market Dominance :
Germany leads Europe's market with $862.4 million in market size, reflecting its position as a hub for biopharmaceutical manufacturing and advanced biotech infrastructure across the continent.
Competitive Regional Landscape :
The UK ($459.9M), France ($192.5M), and Italy ($66.5M) contribute significantly to Europe's market, with emerging opportunities across Spain and other European nations driving diversified growth patterns.
Europe Single-Use Bioreactors Market Dynamics
- The region's commitment to quality standards and innovation creates a favorable environment for single-use technology adoption across major pharmaceutical hubs. Key growth drivers include rising investments in biologics manufacturing, expansion of contract manufacturing organizations (CMOs), and the shift toward flexible, scalable production solutions.
- Europe's aging population and emphasis on personalized medicine further accelerate demand for advanced bioreactor systems, positioning the region for continued market leadership and technological innovation in the global biopharmaceutical sector..
Market Ecosystem
SINGLE-USE BIOREACTORS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Deployed six 4,000 L ABEC CSR single-use bioreactors at its Pune facility to support large-scale manufacturing of Novavax’s NVX-CoV2373 vaccine. | Established 24,000 L of single-use production capacity | The 4,000 L systems doubled productivity per unit of floor space, supported accelerated facility startup, and reduced manufacturing cost per dose. |
 |
Implemented Cytiva Xcellerex Disposable Reactors (XDR) for mAb and bispecific antibody production. | Demonstrated that XDR bioreactors can be used effectively for antibody production | The system met all benchmarks for viable cell density, viability, integral viable cell count (IVC), and titer | The real-time CO2 monitoring proved effective, allowing maintenance of optimal culture conditions. |
 |
Implemented Sartorius Ambr and BIOSTAT STR platforms, ranging from process-development systems to 500 L and 2,000 L single-use bioreactors, at its San Diego biologics facility. | Enabled consistent scale-up from development to GMP production, improved process-data continuity, and supported seamless technology transfer for Phase I through commercial biologics manufacturing. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Europe's single-use bioreactors market will grow from $1,605.4M (2026) to $2,686.5M (2031) at a 10.8% CAGR.
- Europe's advanced regulatory environment and mature CMO sector drive adoption of single-use bioreactor technologies.
- Cell and gene therapy development across Europe is accelerating demand for flexible, scalable bioreactor solutions.
- Europe's focus on reducing manufacturing costs and timelines positions single-use bioreactors as critical infrastructure through 2031.
Single-Use Bioreactors Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | CELL & GENE THERAPY (Molecule Type) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 12% from 2026 to 2031 |
| Largest Segment | BIOPRODUCTION (Application) |
| Market Size Base Year (Billions) | ~USD 5.44 (2026) |
| Revenue Forecast (Billions) | ~USD 9.58 (2031) |
| Segments Covered | Product, Scale Range, Type, Molecule Type, Cell Type, Application, Process Mode, End User |
Europe Single-Use Bioreactors Market Report Segmentation
8 segment dimensions are covered across the global market.
By Product
- Other Products
- Single-Use Assemblies
- Single-Use Bags
- Single-Use Bioreactor Systems
By Scale Range
- 101-500 L Bioreactors
- 11-100 L Bioreactors
- 501-1,500 L Bioreactors
- >1,500 L Bioreactors
- <=10 L Bioreactors
By Type
- 101-500 L Bioreactors
- 11-100 L Bioreactors
- 2D Single-Use Bags
- 3D Single-Use Bags
- 501-1,500 L Bioreactors
- >1,500 L Bioreactors
- Bubble-Column Single-Use Bioreactors
- Fixed-Bed Single-Use Bioreactors
- Other Single-Use Bioreactors
- Stirred-Tank Single-Use Bioreactors
- Wave-Induced Single-Use Bioreactors
- <=10 L Bioreactors
By Molecule Type
- Cell & Gene Therapy
- Monoclonal Antibodies
- Therapeutic Proteins & Peptides
- Vaccines
By Cell Type
- Bacterial Cells
- Mammalian Cells
- Other Cells
- Yeast Cells
By Application
- Bioproduction
- Process Development
- Research & Development
By Process Mode
- Batch Process Mode
- Feb-Batch Process Mode
- Fed-Batch Process Mode
- Perfusion/Continuous Process Mode
By End User
- Academic & Research Institutes
- Cros & Cmos
- Pharmaceutical & Biotechnology Companies
Target Audience
- Biopharmaceutical Manufacturers : European pharma companies require detailed market intelligence on single-use bioreactor adoption trends, competitive positioning, and regulatory compliance strategies to optimize manufacturing operations and maintain market competitiveness.
- Contract Manufacturing Organizations (CMOs) : CMOs operating across Europe need comprehensive market data to identify growth opportunities, benchmark capacity investments, and develop service offerings aligned with regional demand for flexible, scalable bioreactor solutions.
- Equipment & Technology Suppliers : Bioreactor manufacturers and biotech equipment providers require regional market insights to guide product development, pricing strategies, and sales initiatives targeting European pharmaceutical and biotech sectors.
- Investment & Private Equity Firms : Investors evaluating opportunities in European biotech and pharma manufacturing need market sizing, growth forecasts, and competitive analysis to assess investment returns and portfolio company valuations.
- Regulatory & Compliance Consultants : Consultants advising European biotech firms require market data and regulatory insights to guide clients through single-use bioreactor implementation, quality assurance, and compliance with regional standards.
Countries within Europe - compare and drill down
| Country | 2025 size (native) |
|---|---|
| Germany | USD 862.4 Million |
| UK | USD 459.9 Million |
| France | USD 192.5 Million |
| Italy | USD 66.5 Million |
| Spain | USD 46.4 Million |
| Rest Of Europe | USD 316.4 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Sizing & Forecasts : Obtain precise market valuations for Europe ($1,605.4M in 2026) and country-level breakdowns including Germany, UK, France, Italy, and Spain, enabling accurate investment and expansion planning across the region.
- Regulatory & Compliance Insights : Understand Europe's stringent quality standards and regulatory landscape driving single-use bioreactor adoption, critical for manufacturers seeking to navigate compliance requirements and market entry strategies.
- Competitive Landscape Analysis : Identify key market players, growth opportunities, and competitive positioning across major European markets, supporting strategic decision-making for partnerships, acquisitions, and market penetration.
- Growth Driver Identification : Analyze specific factors fueling Europe's 10.8% CAGR, including biopharmaceutical production trends, CMO expansion, and technological innovations, to capitalize on emerging market opportunities.
- Country-Level Strategic Planning : Access detailed market data for individual European countries to develop targeted go-to-market strategies, resource allocation plans, and localized business development initiatives.
Frequently asked questions
What is the current size of Europe's single-use bioreactors market?
Europe's single-use bioreactors market was valued at $1,605.4 million in 2026 and is forecast to reach $2,686.5 million by 2031.
What is the projected growth rate for single-use bioreactors in Europe?
Europe's single-use bioreactors market is expected to grow at a compound annual growth rate (CAGR) of 10.8% from 2026 to 2031.
Why is Europe a key market for single-use bioreactor adoption?
Europe's stringent regulatory standards, advanced healthcare infrastructure, mature CMO ecosystem, and significant investment in cell and gene therapy make it a leading region for single-use bioreactor technology adoption.
Which sectors are driving demand for single-use bioreactors in Europe?
Cell and gene therapy development, contract manufacturing organizations, and biopharmaceutical companies seeking cost-effective and flexible manufacturing solutions are primary drivers of Europe's single-use bioreactor market growth.
How much will Europe's single-use bioreactors market grow by 2031?
Europe's single-use bioreactors market is projected to grow by $1,081.1 million from 2026 to 2031, representing a 67.3% increase over the five-year forecast period.
RESEARCH METHODOLOGY
This research study relied extensively on secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global single-use bioreactors market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives at major market players, and industry consultants, to gather and validate critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with primary research inputs to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-use bioreactors market. The secondary sources used for this study include National Institutes of Health (NIH), National Institute for Bioprocessing Research and Training (NIBRT), Society for Biological Engineering (SBE), Bio-Process Systems Alliance (BPSA), Biotechnology Innovation Organization (BIO), BioProcess International, BioPharm International, BioPlan Associates, Organisation for Economic Co-operation and Development (OECD) R&D Expenditure, National Center for Biotechnology Information (NCBI), World Health Organization (WHO), Food and Drug Administration (FDA); corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, and professional associations, among others. These sources were also used to obtain key information on major players, market classification and segmentation aligned with industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and to assess the market's future prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-use bioreactors market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed where applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Single-use bioreactors (SUBs) or disposable bioreactors consist of a disposable bag instead of a typical stainless steel or glass culture vessel. SUBs are based on single-use technology, which uses disposable components to manufacture biopharmaceutical products. The key benefits of single-use bioreactors include reduced risk of cross-contamination, lower capital and operational costs, faster turnaround times, and greater manufacturing flexibility. These advantages make single-use systems particularly attractive for producing biologics, vaccines, and personalized medicines, where flexibility, speed, and sterility are paramount.
The report presents the market size for single-use bioreactor systems, single-use bags, single-use assemblies, and other products that can be incorporated with single-use bioreactors.
Key Stakeholders
- Manufacturers of single-use bioreactors and associated products
- Distributors of single-use bioreactors and related products
- Pharmaceutical and biotechnology companies
- Contract manufacturing companies (CMOs)
- Contract research organizations (CROs)
- Academic and research institutes
- Life sciences companies
- Market research and consulting firms
- Venture capitalists and investors
- Government organizations
- Medical institutes and universities
- Private research firms
Report Objectives
- To define, describe, and forecast the global single-use bioreactors market based on product, type, cell type, process mode, molecule type, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall single-use bioreactors market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, and R&D activities in the single-use bioreactors market
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the single-use bioreactors market
Available customizations:
Based on the given market data, MarketsandMarkets offers customization to meet the company’s specific needs. The following customization options are available for this report:
Portfolio Assessment- Product Matrix, which gives a detailed comparison of the product portfolios of the top four companies.
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Geographical Analysis
- A further breakdown of the Rest of Europe single-use bioreactors market, by country
- A further breakdown of the Rest of Asia Pacific single-use bioreactors market, by country
- A further breakdown of the Rest of Latin America single-use bioreactors market, by country
Get the Full Single-Use Bioreactors Market Report
Full forecast, segment splits, and company analysis for all Single-Use Bioreactors Market.
- Canada Single-Use Bioreactors Market
- US Single-Use Bioreactors Market
- Germany Single-Use Bioreactors Market
- UK Single-Use Bioreactors Market
- France Single-Use Bioreactors Market
- Italy Single-Use Bioreactors Market
- Spain Single-Use Bioreactors Market
- China Single-Use Bioreactors Market
- South Korea Single-Use Bioreactors Market
- Japan Single-Use Bioreactors Market
- India Single-Use Bioreactors Market
- Australia Single-Use Bioreactors Market
- Brazil Single-Use Bioreactors Market
- Mexico Single-Use Bioreactors Market
- Rest Of Europe Single-Use Bioreactors Market
- Rest Of Asia Pacific Single-Use Bioreactors Market
- Rest Of Latin America Single-Use Bioreactors Market
- Rest Of GCC Countries Single-Use Bioreactors Market
- Saudi Arabia (Ksa) Single-Use Bioreactors Market
- United Arab Emirates (UAE) Single-Use Bioreactors Market
- GCC Countries Single-Use Bioreactors Market
- Rest Of Middle East Single-Use Bioreactors Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
